Overview
Practical Tools & Expert Guidance for the Nurse Navigator and Clinical Team: Strategies to Reduce Treatment Disparities in Multiple Myeloma
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This immersive practice guide offers “how to” methods and day-to-day strategies via faculty commentary and a review of data and guideline recommendations. Expert faculty address which approaches may not be working, complexities in managing this patient population, insights on how the latest evidence supports a practical recommendation and review available therapies to optimize treatment selection.
This activity is intended for oncology nurse navigators, hematology and oncology nurses, hematologists, oncologists, and pharmacists.
The prevalence of MM is higher in some racial/ethnic minorities and these patients are often diagnosed at younger ages than whites. Myriad of disparities in care contribute to worse outcomes in these patients. Drivers of these disparities have been identified in conjunction with markers of risk that can be used to personalize treatment for diverse patients. This guidebook reviews these disparities and provides tools to assist the multidisciplinary care team in ensuring that patients with MM receive that latest care based on patient and clinical factors.
Upon completion of this activity, participants will be able to:
• Outline the latest research relating to MM disparities of care
• Describe strategies to optimally select novel targeted therapies in the frontline and relapsed MM settings considerate of patient- and disease-related factors
• Apply tactics to improve care coordination, access to care and shared decision making for African American and Hispanic MM patients
• Outline the latest research relating to MM disparities of care
• Describe strategies to optimally select novel targeted therapies in the frontline and relapsed MM settings considerate of patient- and disease-related factors
• Apply tactics to improve care coordination, access to care and shared decision making for African American and Hispanic MM patients
Sections
Overview of Disparities
Social Determinants of Health
Evolving Treatment Landscape
Practical Strategies
Overview of Disparities
Social Determinants of Health
Evolving Treatment Landscape
Practical Strategies
This activity is sponsored by the Academy for Continued Healthcare Learning (ACHL) and Purdue University College of Pharmacy.
This activity is supported through independent medical education grants from Amgen Inc., Karyopharm Therapeutics, and Pfizer.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Amy Elizabeth Pierre, BS, MSN
Clinical Director, Research Oncology
Flatiron Health
Nurse Practitioner
Memorial Sloan Kettering Cancer Center
New York, NY
Clinical Director, Research Oncology
Flatiron Health
Nurse Practitioner
Memorial Sloan Kettering Cancer Center
New York, NY
Nina Shah, MD
Professor of Clinical Medicine
University of California - San Francisco (UCSF)
San Francisco, CA
Purdue University College of Pharmacy requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Amy Elizabeth Pierre, BS, MSN
Consultant: Bristol-Myers Squibb
Stock shareholder: Roche
Nina Shah, MD
Advisory role: Amgen, Behring, CareDx, CSL, GSK, Indapta Therapeutics, Karyopharm, Kite Medical, Oncopeptides, Sanofi
Research Funding: Bluebird Bio, Celgene/BMS, Janssen, Nektar, Poseida, Precision Biosciences, Sutro Biopharma, Teneobio
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
Purdue University College of Pharmacy, ACHL staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, as well as the ACPE Accreditation Standards for Continuing Pharmacy Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. Purdue University College of Pharmacy requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 60% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
CPE credit will be submitted to CPE Monitor® on the first day of each month.
Purdue University College of Pharmacy is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Completion of this activity, including the pretest, posttest, and follow-up assessments, qualifies as a medium weight MIPS improvement activity under MACRA and can be claimed as completion of IA_PSPA 28 of an Accredited Safety or Quality Improvement Program in the Quality Payment Program. Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website. You will receive additional information after completing the activity and receiving your certificate via email.
Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/equal opportunity institution.
This activity has been approved for 1.0 contact hour.
ACPE Universal Activity Number: 0018-9999-21-035-H01-P
Activity Type: Application
Release Date: 12/23/21
Expiration Date: 12/23/22
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This program is approved for 1.0 contact hour.
